The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of racial disparities on efficacy and safety outcomes for patients with RRMM receiving T-cell engagers.
 
Lindsay Fogel
No Relationships to Disclose
 
Jaeil Ahn
Consulting or Advisory Role - KeifeRx
 
Adolfo Aleman
No Relationships to Disclose
 
Fideliza Perez-Manon
No Relationships to Disclose
 
Natali Arias-Orozco
No Relationships to Disclose
 
Gabriella Monteleone
No Relationships to Disclose
 
Kiara Londono
Stock and Other Ownership Interests - CVS Health (I)
Research Funding - Ethicon
Travel, Accommodations, Expenses - Ethicon
 
Kathleen Builes
No Relationships to Disclose
 
Harsh Parmar
Consulting or Advisory Role - Cellectar; Cellectar
 
Pooja Phull
Employment - Pfizer (I)
 
David Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Lilly; Merck; Novartis
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Sanofi; Takeda
 
David Siegel
Stock and Other Ownership Interests - COTA
Honoraria - BMS; Envision Pharma Group; Menarini Silicon Biosystems; Merck; Pfizer; Sebia
Consulting or Advisory Role - BMS; Envision Pharma Group; Menarini Silicon Biosystems; Merck; Pfizer; Sebia
 
Andrew Ip
Stock and Other Ownership Interests - Cota Healthcare; Merck (I)
Honoraria - Curio Science; Kite/Gilead
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - Abbvie/Genmab; AstraZeneca; Seagen
Travel, Accommodations, Expenses - Genmab; Seagen
(OPTIONAL) Uncompensated Relationships - COTA; Genomic Testing Cooperative
 
Noa Biran
Employment - Boehringer Ingelheim (I)
Leadership - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Honoraria - Abbvie; Bristol-Myers Squibb; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Janssen; Karyopharm Therapeutics; Merck